CryptocurrencyInvestingBanksReal Estate

Valeant to Report Results on June 7

June 1, 2016, 11:34 AM UTC
Trading At The NYSE As  Valeant Shares Halted Ahead of News Announcement
Photograph by Michael Nagle—Bloomberg via Getty Images

Valeant Pharmaceuticals Inc (VRX), which has come under scrutiny for its business and accounting practices, said on Tuesday it would host a conference call on June 7 to discuss first-quarter results.

The Beleaguered Canadian drugmaker reiterated that it expects to file its quarterly report with U.S. and Canadian regulators on or before June 10, ahead of a July 31 deadline.

The troubled drugmaker filed its 2015 financial report in late April, allaying concerns about a possible default on its debt of more than $30 billion.

The company missed an original March 15 deadline, citing an in-house review of its accounting practices. The probe found problems dating back to 2014. (Reporting by Arathy S Nair in Bengaluru)